BIO:
Felix Boakye-Agyeman, M.D., PhD.
Director, Pharmacometrics
Integrated Drug Development
Certara Strategic Consulting
Felix Boakye- Agyeman is currently a Director of Pharmacometrics with the integrated Drug Development (IDD) group within Quantitative Sciences at Certara. He leads a team of scientists that uses model-based approaches and quantitative methods (pharmacometrics, MBMA etc.) to inform, guide, and supplant traditional development methods.
Prior to joining Certara, Felix was at Syntheract where he managed/mentored a team of scientists in the pharmacometrics department, conducted pharmacometrics analyses and provided pharmacology and pharmacokinetic consulting to clients in both adult and pediatric populations. Prior to joining Syntheract, Felix was with Duke the Clinical Research institute supporting early clinical development, small trials group and the pediatric trials network. Felix completed his Postdoctoral Fellowship in Clinical Pharmacology at the Mayo Clinic. He has broad knowledge of many subject areas including pharmacometrics, bioanalysis, and translational science due to his unique background in medicine, clinical pharmacology and pharmacometrics, laboratory medicine, and public health. He has a particular interest in developmental PK, and accelerating the drug development and labelling processes in pediatric populations.
In his free time, Felix enjoys time with his family, and loves soccer. Felix was born in Ghana and returns there regularly to help train physicians and other allied health personnel. He has helped provide comprehensive updates in clinical medicine through didactic teaching on a broad range of the most preventable and prevalent diseases, including HIV and malaria. He has lectured and helped run several workshops in Ghana through conferences and trainings organized by the Africa Partners Medical a non-profit organization.